Find out whether you should get the RSV vaccine, known as Abrysvo, during pregnancy and when it's recommended.

Residents in public residential aged care services aged 60 and over can now claim a free vaccine for Respiratory Syncytial ...

Public health minister Jenni Minto said the jab would be available for babies born before 32 weeks to protect them over the ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

New research from the Children’s Hospital of Philadelphia shows the challenges of getting families to accept a promising new ...

Higher risk babies can receive the nirsevimab vaccine from September – with the single jab replacing five monthly injections previously given to infants classed as being at high risk.

Premature babies can be given a new vaccine against a potentially life-threatening infection from later this year, the ...

Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

FDA accepts GSK's filing to extend Arexvy's RSV vaccine use to high-risk adults under 50, with a decision due in 2026.

The label expansion sought by GSK is a bid to compete with Pfizer and Moderna in the younger age groups of the RSV vaccine market. Pfizer’s Abrysvo and Moderna’s mRESVIA are both approved to prevent ...

Blog - A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa's private sector but not yet in public clinics. The country's advisory group on ...